Ignite Creation Date:
2024-07-17 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06497985
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-06-28
Brief Title:
Phase III Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSSpMMR Colorectal Cancer Patients
Sponsor:
Chipscreen Biosciences Ltd
Organization:
Chipscreen Biosciences Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-09-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-05-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-06-28
First Submit QC Date:
None
Study First Post Date:
2024-07-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-05
Last Update Post Date:
2024-07-12
Last Update Post Date Type:
ACTUAL